AYA.AU ARTRYA Ltd

Healthcare Health Care Technology Australian Securities Exchange
2.77 AUD
Close of Oct 30, 2026
2.00 6.49
Market cap
AUD 454M
P/E
-
P/B
5.80x
ROE
-32.2%
Dividend yield
-
Fundamental score
1.3/5

Ratios use the latest price and the fiscal year ending Jun 2026.

Is AYA.AU undervalued?

Graham number

The Graham number of ARTRYA Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

ARTRYA Ltd fundamental analysis

5 of 21 checks passed

ROE 0/2

Low return on equity (-32.2%), below 10%.

ROA 1/1

Return on assets (-29.5%) is above the industry median (-45.6%).

Profit Consistency 0/2

Not profitable for at least 3 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share did not grow over the past 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 0/1

Last year's EPS growth (4.5%) is below the industry median (18.9%).

Revenue Growth 0/2

Revenue did not grow over the past 3 years or is not reported.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (0.3%), 40% or less.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Cash Runway 2/2

Cash covers 4.7 years of the current cash burn.

PE vs Market 0/1

PE is negative or not available.

PE vs Industry 0/1

PE is negative or not available.

PBV 0/1

Price to book (5.8x) is above the industry median (5.7x).

Graham Number 0/1

Graham number needs positive earnings and book value.

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

ARTRYA Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About ARTRYA Ltd

Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. It offers Salix, a suite of cloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography scans to identify and manage patients at risk of a heart attack. The company was incorporat…

Full company profile